Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
18 June 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Decavac Articles
Sanofi-Aventis beats expectations with 1st-qtr adjusted EPS rising 53%
15 May 2006
Sanofi-Aventis sales slow on competition
6 February 2006
Showing 1-2 of 2 articles
1
Hot Topics
Most Read
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib